22 - 28 February 2020
These are links to recent news stories about multiple sclerosis that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter, or regular email alerts.
The impact of caring on family members
An MS Society survey shows the degree of unpaid care being provided to people with MS by family members. Two in five provided more than 35 hours care a week and one in six said this was more than 90 hours. One in three respondents said they had given up work to care.
MS Trust link: It's hard to know which way to turn
Relapse risk when switching from Tysabri
Switching from Tysabri to another disease modifying drug didn't lead to an increase in relapses according to a US study of medical records. Previous studies had seen a risk of relapse when switching. People in this study started the new drug sooner (under two months) than in the previous study (four and half months), which may be the important factor
Source: MS News Today
MS Trust link: MS Decisions - a guide to disease modifying drugs for relapsing MS
Receiving an MS diagnosis during my gender transition
22 Feb 2021 - 00:00
Chris shares his experience of being diagnosed with MS at the same time as starting hormone treatment and a surgical gender transition.
David's Diary- Should we all be saying yes to the Covid 19 vaccine?
18 Feb 2021 - 00:00
For the last few weeks our Enquiry Service at the MS Trust has been busy with questions about the vaccination. In his latest blog piece for the MS Trust, CEO David Martin asks the question, 'Should we all be saying yes to the Covid 19 vaccine?'
Monkey sox are back!
17 Feb 2021 - 00:00
...but this time they've gone casual! We are very excited to have partnered once again with Monkey Sox to bring you an exclusive MS Trust design.